This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

19 Jan 2012

Quintiles Invests in Biomarker Research Firm

Quintiles has invested in a new company to provide oncology consulting services and new cancer biomarkers.

US healthcare consultancy Quintiles has invested in a new company, Oxford Cancer Biomarkers. Quintiles is the largest shareholder and other major shareholders are the University of Oxford, Nick La Thangue, Ph.D., chair of Cancer Biology at Oxford University, and David Kerr, professor of Cancer Medicine at the University of Oxford.


The company will develop new cancer biomarkers using CancerNav, a DNA- and protein-based assay technology platform invented by professor Nick La Thangue.


The company will have offices in Oxford and Reading, UK, and will have a strategic relationship with Quintiles Consulting and Quintiles Global Laboratories.


"Biomarkers h

Related News